Fasenra 30 mg

Fasenra 30 mg is a subcutaneous solution containing benralizumab, used for managing asthma symptoms. This medication is designed to help control asthma and improve breathing.

Fasenra 30 mg is primarily used for the maintenance treatment of severe eosinophilic asthma in adults and pediatric patients. It works by reducing the number of eosinophils, a type of white blood cell, which can help manage asthma symptoms. People often ask, 'What is Fasenra used for?' This medication is specifically formulated to target underlying inflammation associated with asthma.

Common effects of Fasenra 30 mg may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience headaches or fatigue. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Fasenra 30 mg should be administered under the guidance of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. Always follow the prescribed dosage and administration instructions to minimize potential risks.

Fasenra 30 mg may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, avoid using Fasenra with other asthma medications unless directed by a healthcare professional.